Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 4/20 | 0.89 |
| ▸ | THRA | P10827 | 3/20 | 0.89 |
| ▸ | NMT1 | P30419 | 1/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.58 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | TDP2 | O95551 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | PLA2G1B | P04054 | 7/20 | 0.56 |
| ▸ | ATG4B | Q9Y4P1 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7820877 | 1.00 | THRB (0.89) | THRBTHRANMT1LPAR2LPAR3 | |
| SCHEMBL28084259 | 0.94 | THRA (1.00) | THRBTHRANMT1PLA2G1BATG4B | |
| SCHEMBL28084264 | 0.94 | THRA (1.00) | THRBTHRANMT1PLA2G1BATG4B | |
| SCHEMBL9354320 | 0.94 | THRA (1.00) | THRBTHRANMT1PLA2G1BATG4B | |
| SCHEMBL9354327 | 0.94 | THRA (1.00) | THRBTHRANMT1PLA2G1BATG4B | |
| SCHEMBL22862119 | 0.92 | THRB (0.76) | THRBTHRANMT1LPAR2LPAR3 | |
| SCHEMBL7821478 | 0.84 | THRB (0.68) | THRBTHRANMT1LPAR2LPAR3 | |
| SCHEMBL2462042 | 0.84 | THRB (0.68) | THRBTHRANMT1LPAR2LPAR3 | |
| SCHEMBL2462040 | 0.84 | THRB (0.68) | THRBTHRANMT1LPAR2LPAR3 | |
| SCHEMBL22862118 | 0.83 | THRB (0.67) | THRBTHRANMT1LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739279-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | Neomics Co., Ltd. (KR) | 2014-06-11 | — | — | EP | claimed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | claimed |
| WO-2013019093-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) | 2013-02-07 | — | — | WO | claimed |
| CN-106317310-B | A kind of acrylamide copolymer and its preparation method and application | 中国石油化工股份有限公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-106317310-A | Acrylamide copolymer, preparation method therefor and application of acrylamide copolymer | 中国石油化工股份有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104418974-B | A kind of preparation method of polyacrylamide emulsion | 中国石油化工股份有限公司 | 2016-08-17 | — | — | CN | disclosed |
| EP-2739279-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | Neomics Co., Ltd. (KR) | 2014-06-11 | — | — | EP | disclosed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | disclosed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | disclosed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | disclosed |
| WO-2013019093-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) | 2013-02-07 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MCL1, GOT2, DDX21 | THRB 3045/4885THRA 3847/4885NMT1 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.